News Archive

2019

November

Media Release / Nov 17, 2019

Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF

Read More
Media Release / Nov 15, 2019

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease

Read More
Media Release / Nov 13, 2019

Novartis launches PsO at Work with music icon Cyndi Lauper to bring to life the impact psoriasis can have in the workplace

Read More
Media Release / Nov 11, 2019

New Novartis data to be presented at American Heart Association SS2019 suggest broader clinical benefit of Entresto in chronic heart failure

Read More
Media Release / Nov 08, 2019

Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More

October

Media Release / Oct 08, 2019

Novartis STEP Program™ now accepting submissions for proposals that address unmet patient needs in cancer biomarker testing

Read More
Media Release / Oct 08, 2019

Novartis receives FDA approval for BEOVU®, offering wet AMD patients vision gains and greater fluid reductions vs aflibercept

Read More
Media Release / Oct 02, 2019

Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum

Read More
Media Release / Oct 01, 2019

Novartis Entresto receives FDA approval for pediatric heart failure, helping to address critical unmet need for treatment options

Read More

September

Media Release / Sep 19, 2019

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

Read More

Related Links